Effektivität des Frühwarnsystems zur Erkennung drohender Medikamentenengpässe

This procedure is a written question aimed at evaluating the effectiveness of the early warning system used to detect imminent shortages of medicinal products. It seeks to ensure that healthcare providers and patients have reliable access to essential medications by identifying supply chain gaps before they become critical. This matter primarily affects patients relying on chronic or acute medications, pharmacists, and healthcare providers who must manage drug availability and find alternatives during shortages.